Collaborators investigate novel T-cell receptor therapy
Drug Discovery World
MARCH 12, 2024
Elicera Therapeutics has entered a Material Transfer Agreement (MTA) with a prominent US cancer centre to evaluate the enhancing effect of the iTANK-technology in a novel T-cell receptor therapy targeting skin cancer and lung cancer.
Let's personalize your content